Figure 1
(A) Patients showing no proliferative response to 105AD7 or human IgG control. (B) Patients showing proliferative response to 105AD7 but not human IgG control (no prevaccination response). (C) Patients showing proliferative response to 105AD7 but not human IgG control (with prevaccination response). T-cell proliferation was assessed by 3H-labelled thymidine incorporation following 5-day stimulation with either 105AD7 or control human IgG: 
An SI of greater than 2 is considered significant. Arrows denote injection with 105AD7 by intrademal (10 μg) and intramuscular (100 μg on alum) injection.
